rs35274867

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000186.4(CFH):​c.3148A>T​(p.Asn1050Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.018 in 1,613,744 control chromosomes in the GnomAD database, including 311 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. N1050N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.019 ( 30 hom., cov: 33)
Exomes 𝑓: 0.018 ( 281 hom. )

Consequence

CFH
NM_000186.4 missense

Scores

2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -1.65
Variant links:
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077705383).
BP6
Variant 1-196743466-A-T is Benign according to our data. Variant chr1-196743466-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 294520.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-196743466-A-T is described in Lovd as [Benign]. Variant chr1-196743466-A-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0192 (2928/152318) while in subpopulation AFR AF= 0.0274 (1140/41588). AF 95% confidence interval is 0.0261. There are 30 homozygotes in gnomad4. There are 1364 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 30 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CFHNM_000186.4 linkuse as main transcriptc.3148A>T p.Asn1050Tyr missense_variant 20/22 ENST00000367429.9 NP_000177.2 P08603A0A024R962

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CFHENST00000367429.9 linkuse as main transcriptc.3148A>T p.Asn1050Tyr missense_variant 20/221 NM_000186.4 ENSP00000356399.4 P08603
ENSG00000289697ENST00000696032.1 linkuse as main transcriptc.3148A>T p.Asn1050Tyr missense_variant 20/27 ENSP00000512341.1 A0A8Q3SIA1

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2929
AN:
152200
Hom.:
30
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0275
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0127
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.0105
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0200
Gnomad OTH
AF:
0.0177
GnomAD3 exomes
AF:
0.0143
AC:
3601
AN:
251412
Hom.:
38
AF XY:
0.0140
AC XY:
1907
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.0289
Gnomad AMR exome
AF:
0.00781
Gnomad ASJ exome
AF:
0.00943
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00722
Gnomad FIN exome
AF:
0.00850
Gnomad NFE exome
AF:
0.0197
Gnomad OTH exome
AF:
0.0192
GnomAD4 exome
AF:
0.0179
AC:
26099
AN:
1461426
Hom.:
281
Cov.:
33
AF XY:
0.0173
AC XY:
12592
AN XY:
727008
show subpopulations
Gnomad4 AFR exome
AF:
0.0270
Gnomad4 AMR exome
AF:
0.00865
Gnomad4 ASJ exome
AF:
0.00884
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00802
Gnomad4 FIN exome
AF:
0.00872
Gnomad4 NFE exome
AF:
0.0201
Gnomad4 OTH exome
AF:
0.0169
GnomAD4 genome
AF:
0.0192
AC:
2928
AN:
152318
Hom.:
30
Cov.:
33
AF XY:
0.0183
AC XY:
1364
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.0274
Gnomad4 AMR
AF:
0.0127
Gnomad4 ASJ
AF:
0.0101
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00663
Gnomad4 FIN
AF:
0.0105
Gnomad4 NFE
AF:
0.0200
Gnomad4 OTH
AF:
0.0175
Alfa
AF:
0.0156
Hom.:
20
Bravo
AF:
0.0200
TwinsUK
AF:
0.0200
AC:
74
ALSPAC
AF:
0.0234
AC:
90
ESP6500AA
AF:
0.0275
AC:
121
ESP6500EA
AF:
0.0223
AC:
192
ExAC
AF:
0.0151
AC:
1835
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0200
EpiControl
AF:
0.0196

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024CFH: BP4, BS1, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hemolytic uremic syndrome, atypical, susceptibility to, 1 Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Basal laminar drusen Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Age related macular degeneration 4 Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
not specified Benign:1
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Factor H deficiency Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Atypical hemolytic-uremic syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenDec 06, 2021- -
Thrombotic microangiopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingJohn Atkinson Laboratory, Washington University School of Medicine in St. LouisJun 20, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
1.7
DANN
Uncertain
0.98
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.075
N
LIST_S2
Benign
0.65
T
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-0.92
T
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.091
Sift
Benign
0.17
T
Sift4G
Benign
0.24
T
Vest4
0.11
MPC
0.18
ClinPred
0.0060
T
GERP RS
-3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35274867; hg19: chr1-196712596; API